Location History:
- Shiga, JP (1995)
- Kurita, JP (1996)
- Kurita-gun, JP (2001)
Company Filing History:
Years Active: 1995-2001
Title: Kazumasa Kishi: Innovator in Pharmaceutical Chemistry
Introduction
Kazumasa Kishi, a remarkable inventor from Kurita-gun, Japan, has made significant contributions to the field of pharmaceutical chemistry. With a total of three patents to his name, Kishi's work primarily focuses on novel chemical compounds that have therapeutic applications, particularly in the treatment of prostate-related conditions.
Latest Patents
Kishi's latest innovations include a pyrimidine derivative, which is represented by a specific general formula, showcasing his ability to develop new and effective chemical structures. Another notable patent is for a condensed pyrazole derivative, which has been shown to inhibit the expression of androgen effectively. This invention is particularly significant for its therapeutic effects on benign prostatic hypertrophy and prostatic carcinoma. The compound, along with its pharmaceutically acceptable salts, demonstrates excellent oral absorption and prolonged efficacy, marking a notable advancement in medicinal chemistry.
Career Highlights
Kazumasa Kishi is currently associated with Otsuka Pharmaceutical Company, Limited, where he has contributed to important research and development efforts in pharmaceutical innovation. His extensive work in creating effective compounds underlines his dedication to enhancing medical treatments and patient outcomes.
Collaborations
Throughout his career, Kishi has collaborated with talented colleagues, including Satoshi Yamada and Takeshi Yamauchi. These partnerships have been crucial in advancing his research and bringing innovative solutions to the pharmaceutical industry.
Conclusion
Kazumasa Kishi stands out as a notable inventor in the pharmaceutical field, with his patented innovations paving the way for potential advancements in treating prostate cancer and benign prostatic hypertrophy. His dedication to inventiveness and collaboration highlights the essential role that innovators play in the development of effective medical therapies.